文献速递区域麻醉与超声疼痛医学

PPX:一种具有感觉选择性的外周与椎管内神经阻滞新药

Sensory-selective Peripheral and Neuraxial Nerve Blockade with 2',6'-Pipecoloxylidide.
PubMed 文献 · Anesthesiology · 2025-07-24

研究在大鼠坐骨神经及鞘内注射2',6'-哌可醇二甲苯胺(PPX)与罗哌卡因(ROP),发现30 mM PPX产生纯感觉阻滞而无运动阻滞,全身毒性低于ROP,组织相容性良好。

要点

  • 30 mM PPX坐骨神经阻滞产生感觉选择性阻滞,持续67.4±17.4分钟,无运动阻滞
  • 鞘内30 mM PPX感觉阻滞持续24.8±8.7分钟,无运动阻滞,可重复注射
  • PPX全身毒性低于ROP,组织反应与ROP相当

核心结论

  • PPX提供感觉选择性局部和椎管内麻醉,安全性良好。
  • 感觉选择性可能归因于PPX特定的亲水-疏水平衡。

研究设计与样本

  • 大鼠坐骨神经注射或鞘内注射PPX或ROP,进行改良热板感觉测试和负重运动测试。
  • 小鼠单纤维记录研究传导阻滞,组织学评估生物相容性。

主要发现

  • 雄性大鼠坐骨神经:15 mM ROP感觉和运动阻滞约150分钟;30 mM PPX感觉阻滞67.4±17.4分钟,无运动阻滞。
  • 鞘内:15 mM ROP感觉和运动阻滞约15分钟;30 mM PPX感觉阻滞24.8±8.7分钟,无运动阻滞,重复注射持续感觉选择性阻滞。
  • 雌性大鼠坐骨神经:ROP阻滞与雄性相似,PPX感觉选择性但需更高浓度。
  • 离体:1.5 mM ROP可逆阻断Aδ和C纤维;15 mM PPX阻断Aδ但不阻断C纤维。
  • 全身毒性:39.0±1.8 mg/kg ROP引起严重临床毒性;75.3±3.2 mg/kg PPX无毒性。

临床怎么用

  • PPX可能作为感觉选择性局麻药用于急性或慢性疼痛管理,避免运动阻滞。
  • 需进一步临床研究验证其安全性和有效性。

局限性

  • 研究仅在大鼠和小鼠中进行,尚未在人体验证。
  • 化学渗透促进剂加入PPX后感觉选择性消失。
  • 雌性大鼠需要更高浓度PPX达到感觉选择性阻滞。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Safe sensory-selective local anesthetics would be a major advance in the management of acute and chronic pain. This articles describes the sensory-selective local anesthetic properties and the toxicity profile of a known metabolite of amino-amide local anesthetics, 2',6'-pipecoloxylidide (PPX). METHODS: PPX was synthesized and made into its hydrochloride salt. PPX or ropivacaine (ROP) were injected at the sciatic nerve or intrathecally in rats, who then underwent modified hotplate (sensory) testing and weight-bearing (motor) testing. Rats injected with PPX or ROP were assessed for clinical toxicity endpoints. Conduction blockade was studied with single-unit recordings in mice. Biocompatibility was assessed histologically. RESULTS: In male rats, sciatic sensory and motor block from 15 mM ROP lasted approximately 150 min; sensory nerve block from 30 mM PPX lasted 67.4 ± 17.4 min without motor block. The addition of chemical permeation enhancers to 30 mM PPX abolished sensory selectivity. Intrathecal 15 mM ROP produced sensory and motor block lasting approximately 15 min; sensory block from 30 mM PPX lasted 24.8 ± 8.7 min without motor block; repeated injection caused continuous sensory-selective block. In female rats, sciatic nerve blocks with ROP were similar to blocks in males, while blocks with PPX were sensory-selective, but higher PPX concentrations were required. Ex vivo , 1.5 mM ROP caused reversible block of Aδ and C-fibers; 15 mM PPX blocked Aδ-fibers but not C-fibers. Systemic 39.0 ± 1.8 mg/kg ROP caused severe clinical toxicity; 75.3 ± 3.2 mg/kg PPX caused none. Tissue reaction to PPX was benign, comparable to that of ROP. CONCLUSIONS: PPX provides sensory-selective local and neuraxial anesthesia with a good safety profile. The sensory selectivity may be attributable to the particular hydrophilic-hydrophobic balance of PPX.

来源:Anesthesiology,查看原文。版权归原作者所有。

引用

  1. Ostertag-Hill CA, Chen S, Xue T, et al. Sensory-selective Peripheral and Neuraxial Nerve Blockade with 2',6'-Pipecoloxylidide. Anesthesiology. 2025. PMID: 40704591. doi:10.1097/ALN.0000000000005679

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。